$270,000 Drug. One Competitor. Billion-Dollar Market.
Phase 3 trial targets recurrent pericarditis with an oral therapy that could disrupt the only approved treatment. And their heart failure program launches in 2026.
Shares Stats
| Shares Outstanding | 33,380,000 |
| Shares Float | 32,760,000 |
| Shares Short | 720,000 |
| Insider Holdings | 415% |
| Institution Holdings | 86.73% |
About Walker & Dunlop Inc
Walker & Dunlop, Inc., through its subsidiaries, originates, sells, and services a range of multifamily and other commercial real estate financing products and services for owners and developers of real estate in the United States. It operates through three segments: Capital Markets, Servicing & Asset Management, and Corporate. The company offers first mortgage, second trust, supplemental, construction, mezzanine, preferred equity, and small-balance loans. It also provides finance for multifamily, manufactured housing communities, student housing, affordable housing, and senior housing properties under the Fannie Mae's DUS program; and construction and permanent loans to developers and owners of multifamily housing, affordable housing, senior housing, and healthcare facilities. In addition, the company acts as a debt broker to work with life insurance companies, banks, and other institutional lenders to find debt and/or equity solution for the borrowers' needs; and offers property sales brokerage services to owners and developers of multifamily properties, and commercial real estate and multifamily property appraisals for various investors. Further, it provides multifamily appraisal and valuation services; and real estate-related investment banking and advisory services, including housing market research. Additionally, the company offers servicing and asset-managing the portfolio of loans; originates loans through its principal lending and investing activities; and manages third-party capital invested in tax credit equity funds focused on the LIHTC sector and other commercial real estate sectors. Walker & Dunlop, Inc. was founded in 1937 and is headquartered in Bethesda, Maryland.
General
| Name | Walker & Dunlop Inc |
| Ticker | WD |
| Exchange | NYSE |
| Sector | Financial |
| Industry | Mortgage Finance |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 1,399 |
Highlights
| Analyst Target | 93.50 |
| Market Cap | 2,189,300,000 |
| PE Ratio | 19.07 |
| PEG Ratio | 1.25 |
Financials
| Curr Year EPS Estimate | 4.10 |
| Next Quarter EPS Estimate | 1.46 |
| Profit Margin | 9.35% |
| Operating Margin | 16.52 |
| Return on Assets | 0.02 |
| Return on Equity | 0.06 |
| Revenue | 1.2B |
| Earnings Per Share | 3.37 |
| Revenue Per Share | 34.84 |
| Gross Profit | 1,160,070,016 |
| Quarterly Revenue Growth | 0.18 |
Valuation
| Trailing PE | 19.18 |
| Forward PE | 10.99 |
| Price/Sales (Trailing 12 Mt.) | 1.90 |
| Price/Book (Most Recent Quarter) | 1.25 |
Dividend
Walker & Dunlop Inc pays out a dividend of $2.68 per share, with a dividend yield of 4.17%.
WD's next dividend payment will be made to shareholders on December 5, 2025.
They pay out 81.54% of their earnings out as a dividend.
Recent Dividends
| Dec 5, 2025 | $0.67 |
| Sep 5, 2025 | $0.67 |
| May 29, 2025 | $0.67 |
| Mar 14, 2025 | $0.67 |
| Dec 6, 2024 | $0.65 |
| Sep 6, 2024 | $0.65 |
| May 31, 2024 | $0.65 |
| Mar 15, 2024 | $0.65 |
AP Lifestyles Digest for week of Dec. 1
Here is the AP Lifestyles Digest for the week of Dec. 1. Note AP's Holiday Gift Guide Digest moved Nov. 12 and is included at the end.
Trump's Approval Rating Hits Lowest Since Returning To Office, With Support Falling Among Republicans, Independents
Trump's approval rating hits new low as Republican and independent support drops. Economy, immigration, and budget handling are major concerns.
A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
Trump Threatens Air Traffic Controllers Amid Shutdown Chaos; Pete Buttigieg Says He 'Wouldn't Last Five Minutes' in Their Job
President Donald Trump has demanded that all air traffic controllers return to work as the nation's aviation system endured another wave of mass flight cancellations, caused by staffing shortages due to the prolonged government shutdown.
Velo3D Stock Soars After Q3 Earnings: Highlights From The Report
Shares of Velo3D, Inc. (NASDAQ:VELO) are rising Tuesday after the metal 3D printing company reported third-quarter earnings results.
First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad
This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.
16 Stocks To Buy If You Want To Escape The AI Hype
Bank of America is pointing investors toward 16 overlooked stocks with strong fundamentals and no direct ties to the AI boom—offering a safer path beyond the hype.
Chuck Schumer Says 41-Day Shutdown Has Exposed Trump's 'Cruelty,' Accuses President Of Holding Innocent Kids, Veterans As 'Political Hostages'
Schumer condemns Trump's 'cruelty' behind longest shutdown in U.S. history, as thousands of Americans suffer from furloughs and disrupted services.
The Smart Money Copper Trade - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Noem Says National Guard Shooting Suspect Was Radicalized In US
DHS Secretary Kristi Noem says that the suspect in the fatal shooting of a National Guard member in Washington was radicalized domestically.
Trump commutes prison sentence for former private equity executive David Gentile
HALLANDALE BEACH, Fla. (AP) — President has commuted the prison sentence of former investment manager David Gentile, who was convicted of defrauding investors — the latest in a Trump has taken in .
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
Cathie Wood Dumps $11.6 Million Worth Of Tesla Stock: Here Is What Ark Purchased Instead
On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Tesla Inc. (NASDAQ:TSLA), Coinbase Global Inc.
Coreweave, Rocket Lab, AST Spacemobile, Rigetti And Bigbear.Ai: Why These 5 Stocks Are On Investors' Radars Today
Major U.S. indexes closed higher on Monday, with the Dow Jones Industrial Average climbing 0.8% to 47,368.63.
Copper, Silver, Gold, Tungsten - This Nevada Play Offers Multiple Shots on Goal - Ad
Most early-stage resource opportunities rely on one metal. This one doesn't. The Walker Lane belt hosts copper, silver, gold, and tungsten - and recent results across the district confirm all four. This startup has stepped in with multi-metal exposure, giving investors several potential ways to capture upside.
How Tyson's Chicken Business Will Offset Beef Weakness
Tyson shares rise as pricing catch-up expected to ease cost pressures; chicken strength offsets beef headwinds amid stable feed costs.
Trump attacks ABC News correspondent Mary Bruce in angry response to three sharp questions
NEW YORK (AP) — President Donald Trump denounced ABC News' Mary Bruce as a “terrible reporter” Tuesday and threatened the network's license to broadcast after she asked him three sharp questions at the White House.
Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad
AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.
A lost generation of news consumers? Survey shows how teenagers dislike the news media
NEW YORK (AP) — Cat Murphy, a college student, has wanted to be a journalist since she was 11. Many of her friends don't understand why.
Tax-Free Student Loan Forgiveness Expires In 2026, Who Owes More Next Year?
The American Rescue Plan Act of 2021 will make most student loan forgiveness tax-free until 2025, then borrowers may owe thousands in taxes.
Trump Just Signed s.1582 Into Law - Now the Countdown Begins... - Ad
A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on December 18. Investors who make the right moves before then could make up to 40X by 2032...
XRP Jumps 10% In A Week As First-Ever Spot ETF Eyes Thursday Launch
XRP (CRYPTO: XRP) surged 10% over the past seven days amid mounting anticipation for the first-ever XRP ETF, which could launch as early as this week.
Elon Musk Says Tesla, xAI Are 'Trending Towards Convergence' In Some Ways
Elon Musk's companies could potentially merge in the future as he continues to integrate AI into his ventures.
Urgent Copper Stock With Strong Catalysts - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact
BofA expects Medtronic to post over 5% second-quarter revenue growth and maintain strong momentum through 2026, driven by robust procedure trends.
Joan Branson, wife of British billionaire Richard Branson, dies at 80
Joan Branson, the wife of British billionaire Richard Branson, has died at age 80.
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
Apple pulls two gay dating apps in China under government order
BANGKOK (AP) — Apple said it has pulled two of China’s biggest gay dating apps, Blued and Finka, under pressure from Chinese authorities, in the latest sign of a tightening grip on the LGBTQ+ community.
OpenAI's Partners Rake Up $96 Billion Debt as AI Industry's Borrowing Trend Escalates
Companies supplying data centers, chips, and processing power to OpenAI have racked up a staggering $96 billion in debt to fund their operations.
$270,000 Drug. One Competitor. Billion-Dollar Market. - Ad
Phase 3 trial targets recurrent pericarditis with an oral therapy that could disrupt the only approved treatment. And their heart failure program launches in 2026.
Trump Bars South Africa From 2026 G20 Summit In Florida, Freezes Aid Over 'White Genocide'
President Donald Trump directed that South Africa will not be invited to the 2026 G20 Summit in Miami, Florida. He also declared that all U.S. payments and subsidies to the country would be immediately suspended.
Serbian protesters vow to prevent real estate project linked to Trump son-in-law Kushner
BELGRADE, Serbia (AP) — Thousands of protesters in Serbia symbolically formed a human shield Tuesday around a bombed-out military complex, vowing to protect it from redevelopment as a luxury compound by a company linked to U.S. President Donald Trump’s son-in-law .
A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
Gen Z Takes To 'Income Stacking' As One Pay Check Falls Short
Gen Zers are turning to income stacking to secure their financial future as they fear a single paycheck won't be enough. AI and broken social contract fuel the shift. Side hustles becoming core of young careers.
(Micro)Strategy's Structural Reset: Why Markets Are Repricing MSTR Beyond Bitcoin
The recent decline in Strategy's (NASDAQ:MSTR) stock price is not a simple pullback, nor is it a reaction driven by short-term sentiment. What is unfolding around MSTR is a broad structural repricing.
First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad
This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.
Weekend Crypto Roundup: Bitcoin's Scarcity, Dogecoin's Resistance, Tether's Rating, Trump's Crypto Ties And Peter Schiff's Warning
From Bitcoin's scarcity debate to Dogecoin's resistance level, the crypto market was buzzing with activity this past week.
US Senate Discloses Landmark Crypto Market Structure Bill, Eyes Passage By Late 2025
Bitcoin (CRYPTO: BTC) is holding steady near $105,000 as markets digest the Senate's long-awaited crypto market structure bill draft, a major milestone toward regulatory clarity
The Smart Money Copper Trade - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Why Is Occidental Petroleum Stock Gaining Tuesday?
Analysts highlight OXY's robust earnings, production guidance, and expanded resource base as key growth drivers.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.